Research Topics
| Xavier Saez-LlorensSummaryCountry: Panama Publications
| Collaborators
|
Detail Information
Publications
Brain abscessXavier Saez-Llorens
Pediatric Infectious Diseases Department, Hospital del Nino, Panama, Republic of Panama Electronic address
Handb Clin Neurol 112:1127-34. 2013..Duration of anticonvulsant therapy should be individualized and guided by electroencephalographic (EEG) study in the follow-up phase of disease...
[Complications and costs associated with chickenpox in immunocompetent children]Xavier Saez-Llorens
Departamento de Infectologia, Hospital del Nino, Panama, Republica de Panama
Rev Panam Salud Publica 12:111-6. 2002..In addition, the hospital costs associated with chickenpox in the studied children were calculated...
Brain abscess in childrenXavier Saez-Llorens
University of Panama School of Medicine, Hospital del Nino, Panama City, Panama
Semin Pediatr Infect Dis 14:108-14. 2003..In the early phase of cerebritis, however, infection can respond to antibiotic therapy alone. Advances in diagnostic and therapeutic modalities during the last decade have improved the prognosis of this serious disease...
Bacterial meningitis in childrenXavier Saez-Llorens
University of Panama School of Medicine, Hospital del Nino, Panama City, Panama
Lancet 361:2139-48. 2003..Novel strategies are needed to distribute and implement effective vaccines worldwide to prevent bacterial meningitis...
Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected childrenXavier Saez-Llorens
Hospital del Nino, Panama City, Panama
Pediatr Infect Dis J 22:216-24. 2003..Lopinavir/ritonavir has demonstrated antiviral activity in the HIV-infected adult...
Glycerol and bacterial meningitisXavier Saez-Llorens
Department of Infectious Diseases, University of Panama School of Medicine, Hospital del Nino, Panama City, Panama
Clin Infect Dis 45:1287-9. 2007
Intussusception and rotavirus vaccines: what is the background risk?Xavier Saez-Llorens
Pediatrics, University of Panama, Panama City, Panama
Pediatr Infect Dis J 23:363-5. 2004..A 5-year retrospective study conducted in Panama found an average rate of 1 case per 3300 infants younger than 1 year of age, with substantial yearly variations ranging from 1:2500 to 1:5000...
Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infectionXavier Saez-Llorens
Division of Infectious Diseases, Hospital del Nino, University of Panama School of Medicine
Pediatr Infect Dis J 23:707-12. 2004..Limited treatment options exist. Palivizumab is a humanized monoclonal IgG1 antibody to the fusion protein of RSV that is highly active against RSV A and B strains...
Long-term safety and efficacy results of once-daily emtricitabine-based highly active antiretroviral therapy regimens in human immunodeficiency virus-infected pediatric subjectsXavier Saez-Llorens
Infectious Disease Department, Hospital del Nino, Panama City, Panama
Pediatrics 121:e827-35. 2008....
Impact of routine fluconazole prophylaxis for premature infants with birth weights of less than 1250 grams in a developing countryKathia Rueda
División Neonatología, Hospital del Nino, Panama
Pediatr Infect Dis J 29:1050-2. 2010..1%, P = 0.003). Routine fluconazole prophylaxis given to premature infants of less than 1250 g at birth is associated with a significant impact on frequency of documented systemic Candida infections...
Randomized, investigator-blinded, multicenter study of gatifloxacin versus amoxicillin/clavulanate treatment of recurrent and nonresponsive otitis media in childrenXavier Saez-Llorens
Departamento de Infectologia, Hospital del Nino, Panama City, Panama
Pediatr Infect Dis J 24:293-300. 2005..Decreased susceptibility of pathogens to currently used agents for recurrent otitis media has provided the impetus for identifying new antimicrobial options...
Pharmacokinetics and safety of caspofungin in neonates and infants less than 3 months of ageXavier Saez-Llorens
Hospital del Nino, Panama City, Panama
Antimicrob Agents Chemother 53:869-75. 2009..However, the small number of patients studied precludes any definitive recommendations about caspofungin dosing for this group comprising a broad range of ages and weights...
